Documente Academic
Documente Profesional
Documente Cultură
• Calitatea plansului
• Reactia la calitatea plansului
• Variatie de stare (state variation)
• Culoare
• Hidratare
• Raspuns la ambianta (ouverture) sociala
LCR NA < 10 NA
Optiunea 2
HemoCx, UroCx
Baraff Annals EM 2000 F/U 24hrs
Regula de decizie clinica
•Studiu multicentric, prospectiv
• Sugar febril cu varsta < 60 zile
• 1045 sugari
• 122 cu IBS (11.7%)
• ITU 103 (10%)
• Bacteremie 23 (2.2%)
• Meningite 7 (0.06%)
• Enterite 2 (0.02%)
Levine In Press
Arbore 122 (+SBI) 11.7%
923 (-SBI) 88.3%
Examen de urina
negativ ?
YES Nu
37 (+SBI) 4% 85 (+SBI) 49%
835 (-SBI) 96% 88 (-SBI) 51%
872 Total (83%) 173 Total (17%)
Tmax < 38.8 oC ?
Da Nu
15 (+SBI) 2.5% 22 (+SBI) 8%
578 (- SBI) 97.5% 257 (-SBI) 92%
593 Total (57%) 279 Total (27%)
Da Nu
11 (+SBI) 1.9% 4 (+SBI) 16.7%
558 (-SBI) 98.1% 20 (-SBI) 83.3%
569 Total (54%) 24 Total (2.3%)
Necesitatea punctiei lombare
(PL)
• Date limitate-rezultate rare
• Nu e inclusa in Criteriul Rochester
• Fara meningite omise
• Fara rezultate adverse in absenta efectuarii PL
• Majoritatea pleiocitozelor sunt non-bacteriene
• Criterii Rochester
• 4/5 IBS w/o terapie pana la cultura (+)
• Protocol Philadelphia
• 1 bacteremie w/o terapie pana la cultura
(+)
• Intarzierea efectuarii Rx afecteaza
rezultatul?
Este necesara spitalizarea?
• DeAngelis - Am J Dis Child 1983
• Complicatii iatrogene
• 37(19.5%)/190 admisii
• 1 stolen infant
• 10 skin sloughing
• Baker - N Engl J Med 1993
rata complicatiilor la inpatient group
Aderenta la protocoale
P n eu m ovax
NO YE S
L a b o ra to ry S c re e n in g W /U R x
CBC, BCx N on e
C los e F /U
E m p iric A B x
( C T X IM )
W B C > 1 5 K or
ANC > 10K
Bacteremie % Meningite(95%CI)
Toate organismele 9.8 % ( 7.4 - 12.7)
Strep pneumo 5.8 % ( 3.4 - 8.8 )
Hflu tip B 26.6 % ( 18.3 - 36.3)
NO CBC
LAB EVAL
A N C < 1 0 ,0 0 0 A N C > = 1 0 ,0 0 0
No BCx BCx
No ABx E m p iric A B x
(O P B ris k 0 .7 % ) (O P B ris k 8 .2 % )
Sechele OR 95% CI P
IBS .35 (.17 - .73) .003
Meningite .51 (.12 - 2.1) .345
Sechele OR 95% CI P
Total0.43 0.08-1.8 .31
Definite 0.00 0.00-0.52 .02
Febra persistenta 0.52 0.52-0.94 .04
Fleisher J PEDS 124(4) APR 1994
Empiric Antibiotics
Parenteral vs Oral
• Meta-analiza (4 studii)
• Numai OPB (N=511)
Sechele PO IM OR (95%CI) P
ISB 3.4 2.3 1.48 (0.5-4.3) .47
Meningite 0.7 0.9 0.67 (0.1-5.1) .70
• N = 2411
• FWS M < 1an, F < 2ani, T >= 38.5
• 80 % cu surse potentiale - URI, OM
• 3.3 % ( 2.6 - 4.0 )
Test Sensibilitate
Enhanced UA * 91 %
Leucocit esteraza 53 %
Nitrit 31 %